Immuno-Oncology

Webinar Series

 2020

LUMICKS invites you to attend our Immuno-Oncology (IO) webinars.

 

The series of webinars, delivered by our application scientists or by invited speakers, cover topics across the field of immunotherapy, such as CAR-T and TCR T-cell therapy .

If you are curious about cell avidity or are looking for a new workflow that can help you predict the immunotherapeutic potential of your cells, click on the link below to register to our webinars or download recordings!

Jump to:

Upcoming Webinars

Deep-dive into the applications with LUMICKS’ scientists.

Join our upcoming webinars presented by LUMICKS’ scientists and covering the latest breakthroughs and developments in immuno-oncology.

Rapid identification of Goldilocks CAR T cells using z-Movi® Cell Avidity Analyzer

In this webinar we demonstrate that measuring cellular avidity, i.e. overall binding strength between effector and target cell, using z-Movi® Cell Avidity Analyzer can help quickly identify optimal functioning CARs.

Learning objectives:
• How z-Movi measures cellular avidity.
• Why avidity matters in CAR-dependent T-cell cytotoxicity.
• How cell avidity measurements compare with functional assays.

Date: Wednesday, 8 July 2020

Speaker: Dr. Rogier Reijmers, Principal Scientist Immuno-Oncology, LUMICKS

Rapid identification of Goldilocks CAR T cells using z-Movi® Cell Avidity Analyzer

In this webinar we demonstrate that measuring cellular avidity, i.e. overall binding strength between effector and target cell, using z-Movi® Cell Avidity Analyzer can help quickly identify optimal functioning CARs.

Learning objectives:
• How z-Movi measures cellular avidity.
• Why avidity matters in CAR-dependent T-cell cytotoxicity.
• How cell avidity measurements compare with functional assays.

Date: Wednesday, 8 July 2020

Speaker: Dr. Rogier Reijmers, Principal Scientist Immuno-Oncology, LUMICKS

External Application Webinars

Watch seminars from world-leading experts.

Don’t miss researchers from external institution talk about their experience with cell avidity measurements for T cell functionality prediction.

Date: September (Exact date to be determined)

Speaker: Dr. John Maher, Leucid Bio

Ranking affinity-tuned CAR T cells: A faster way to predict tumor only CAR T cell functionality

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Watch Past Webinars

Missed a webinar? 

Watch it on-demand below. A video recording and a slide deck are now available on our website.

Cell avidity – the best predictor for clinical efficacy of T-cell therapy?

Affinity between immune-cell receptors and their antigens has been shown to be a poor predictor of T-cell functionality. The webinar discussed the benefits of avidity, a new parameter to assess functionality of immune cells, with the potential to improve workflows for the development of immunotherapy against cancer.

To this end, we presented proof-of-concept experiments across the topics of CAR-T cells, TCR T cells, NK cells and bispecific antibody-engaged T cells, showing correlation between avidity and T cell functionality.

We introduced the z-Movi® Cell Avidity Analyzer, a novel and unique instrument that makes use of ultrasound to directly measure the avidity between immune cells and their target cancer cells.

Speaker: Dr. Rogier Reijmers, Principal Scientist Immuno-Oncology, LUMICKS

Fast and accurate prediction of optimal TCR function using z-Movi® Cell Avidity Analyzer

In this webinar, we show the ease of use of the z-Movi and how to quickly acquire cellular avidity data, a valuable new parameter to assess T-cell functionality, using T cells expressing transgenic TCRs for immunotherapy development.

Learning objectives:
• How z-Movi measures cellular avidity.
• Why avidity matters in TCR-dependent T-cell cytotoxicity.
• How cell avidity measurements compare with in vitro functional assays.

Date: Wednesday, 24 June 2020

Speaker: Dr. Rogier Reijmers, Principal Scientist Immuno-Oncology, LUMICKS

Fast and accurate prediction of optimal TCR function using z-Movi® Cell Avidity Analyzer

In this webinar, we show the ease of use of the z-Movi and how to quickly acquire cellular avidity data, a valuable new parameter to assess T cell functionality, using T cells expressing transgenic TCRs for immunotherapy development.

Learning objectives:
• How z-Movi measures cellular avidity.
• Why avidity matters in TCR-dependent T-cell cytotoxicity.
• How cell avidity measurements compare with in vitro functional assays.

Date: Wednesday, 24 June 2020

Speaker: Dr. Rogier Reijmers, Principal Scientist Immuno-Oncology, LUMICKS

Fill in the form below to watch previously-held webinars. If you miss something don’t hesitate to let us know!

Join our mailing list.

Get exclusive news on the latest products, single-molecule events and breakthrough science.

By agreeing to receive marketing communications, you subscribe to our newsletter. You can change your mind at any time by clicking the unsubscribe link in any marketing email you receive from us. By submitting the form you agree to LUMICKS' privacy policy.

Take your research to the next level.

Get exclusive news on the latest products, single-molecule events and breakthrough science.

Newsletter pop up
By clicking the subscribe button you agree to LUMICKS’ privacy policy.